Guillaume Cartron, Sophie de Guibert, Marie-Sarah Dilhuydy, Franck Morschhauser, Veronique Leblond, et al.. Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study.
Blood, American Society of Hematology, 2014, 124 (14), pp.2196--2202.
⟨10.1182/blood-2014-07-586610⟩.
⟨hal-01147035⟩